{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T01:30:46Z","timestamp":1776216646070,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Gansu Province Youth Science and Technology Fund Project","award":["23JRRA1006"],"award-info":[{"award-number":["23JRRA1006"]}]},{"name":"Gansu Province Youth Science and Technology Fund Project","award":["23JRRA1006"],"award-info":[{"award-number":["23JRRA1006"]}]},{"name":"Gansu Province Youth Science and Technology Fund Project","award":["23JRRA1006"],"award-info":[{"award-number":["23JRRA1006"]}]},{"name":"Gansu Provincial Department of Education Innovation Fund Project","award":["2022B-049"],"award-info":[{"award-number":["2022B-049"]}]},{"name":"Gansu Provincial Department of Education Innovation Fund Project","award":["2022B-049"],"award-info":[{"award-number":["2022B-049"]}]},{"name":"Gansu Provincial Department of Education Innovation Fund Project","award":["2022B-049"],"award-info":[{"award-number":["2022B-049"]}]},{"name":"Science and Technology Plan Project of Lanzhou Science and Technology Bureau","award":["2023-4-34"],"award-info":[{"award-number":["2023-4-34"]}]},{"name":"Science and Technology Plan Project of Lanzhou Science and Technology Bureau","award":["2023-4-34"],"award-info":[{"award-number":["2023-4-34"]}]},{"name":"Central Guiding Local Science and Technology Development Funds","award":["24ZYQA050"],"award-info":[{"award-number":["24ZYQA050"]}]},{"name":"Central Guiding Local Science and Technology Development Funds","award":["24ZYQA050"],"award-info":[{"award-number":["24ZYQA050"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03709-3","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T12:51:13Z","timestamp":1760446273000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Circulating metabolites and bladder cancer: a Mendelian randomization and multi-omics study"],"prefix":"10.1007","volume":"16","author":[{"given":"Zhe","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jirong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongjian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"issue":"10364","key":"3709_CR1","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/S0140-6736(22)01188-6","volume":"400","author":"E Comp\u00e9rat","year":"2022","unstructured":"Comp\u00e9rat E, Amin MB, Cathomas R, et al. Current best practice for bladder cancer: a narrative review of diagnostics and treatments. Lancet. 2022;400(10364):1712\u201321. https:\/\/doi.org\/10.1016\/S0140-6736(22)01188-6.","journal-title":"Lancet"},{"issue":"1","key":"3709_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","volume":"79","author":"JA Witjes","year":"2021","unstructured":"Witjes JA, Bruins HM, Cathomas R, et al. European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur Urol. 2021;79(1):82\u2013104. https:\/\/doi.org\/10.1016\/j.eururo.2020.03.055.","journal-title":"Eur Urol"},{"key":"3709_CR3","doi-asserted-by":"publisher","unstructured":"Alfred Witjes J, Max Bruins H, Carri\u00f3n A, et al. European Association of Urology Guidelines on Muscle-invasive and Metastatic bladder cancer: summary of the 2023 Guidelines. Eur Urol. 2024;85(1):17\u201331. https:\/\/doi.org\/10.1016\/j.eururo.2023.08.016. Epub 2023 Oct 17. Erratum in: Eur Urol. 2024;85(6):e180. doi: 10.1016\/j.eururo.","DOI":"10.1016\/j.eururo.2023.08.016"},{"issue":"15","key":"3709_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158597","volume":"23","author":"M Matuszczak","year":"2022","unstructured":"Matuszczak M, Kilja\u0144czyk A, Salagierski M. A liquid biopsy in bladder cancer-the current landscape in urinary biomarkers. Int J Mol Sci. 2022;23(15):8597. https:\/\/doi.org\/10.3390\/ijms23158597.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3709_CR5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12859-021-04235-z","volume":"22","author":"JY Lin","year":"2021","unstructured":"Lin JY, Juo BR, Yeh YH, et al. Putative markers for the detection of early-stage bladder cancer selected by urine metabolomics. BMC Bioinformatics. 2021;22(1):305. https:\/\/doi.org\/10.1186\/s12859-021-04235-z.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"3709_CR6","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12885-022-09318-5","volume":"22","author":"R Wang","year":"2022","unstructured":"Wang R, Kang H, Zhang X, et al. Urinary metabolomics for discovering metabolic biomarkers of bladder cancer by UPLC-MS. BMC Cancer. 2022;22(1):214. https:\/\/doi.org\/10.1186\/s12885-022-09318-5.","journal-title":"BMC Cancer"},{"issue":"6","key":"3709_CR7","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.jpha.2022.08.004","volume":"12","author":"K Ossoli\u0144ski","year":"2022","unstructured":"Ossoli\u0144ski K, Ruman T, Copi\u00e9 V, et al. Metabolomic and elemental profiling of blood serum in bladder cancer. J Pharm Anal. 2022;12(6):889\u2013900. https:\/\/doi.org\/10.1016\/j.jpha.2022.08.004.","journal-title":"J Pharm Anal"},{"issue":"7","key":"3709_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11306-019-1555-9","volume":"15","author":"VL Kouznetsova","year":"2019","unstructured":"Kouznetsova VL, Kim E, Romm EL, et al. Recognition of early and late stages of bladder cancer using metabolites and machine learning. Metabolomics. 2019;15(7):94. https:\/\/doi.org\/10.1007\/s11306-019-1555-9.","journal-title":"Metabolomics"},{"issue":"5","key":"3709_CR9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1080\/14737159.2019.1604223","volume":"19","author":"G Lucarelli","year":"2019","unstructured":"Lucarelli G, Loizzo D, Ferro M, et al. Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update. Expert Rev Mol Diagn. 2019;19(5):377\u201387. https:\/\/doi.org\/10.1080\/14737159.2019.1604223.","journal-title":"Expert Rev Mol Diagn"},{"issue":"4","key":"3709_CR10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/14737159.2023.2195553","volume":"23","author":"NA di Meo","year":"2023","unstructured":"di Meo NA, Lasorsa F, Rutigliano M, et al. The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery. Expert Rev Mol Diagn. 2023;23(4):297\u2013313. https:\/\/doi.org\/10.1080\/14737159.2023.2195553.","journal-title":"Expert Rev Mol Diagn"},{"key":"3709_CR11","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/j.csbj.2022.05.015","volume":"20","author":"FJ Boehm","year":"2022","unstructured":"Boehm FJ, Zhou X. Statistical methods for Mendelian randomization in genome-wide association studies: a review. Comput Struct Biotechnol J. 2022;20:2338\u201351. https:\/\/doi.org\/10.1016\/j.csbj.2022.05.015.","journal-title":"Comput Struct Biotechnol J"},{"issue":"8","key":"3709_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084173","volume":"23","author":"NA di Meo","year":"2022","unstructured":"di Meo NA, Loizzo D, Pandolfo SD, et al. Metabolomic approaches for detection and identification of biomarkers and altered pathways in bladder cancer. Int J Mol Sci. 2022;23(8):4173. https:\/\/doi.org\/10.3390\/ijms23084173.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3709_CR13","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1186\/s12888-023-05081-4","volume":"23","author":"C Wang","year":"2023","unstructured":"Wang C, Zhu D, Zhang D, et al. Causal role of immune cells in schizophrenia: Mendelian randomization (MR) study. BMC Psychiatry. 2023;23(1):590. https:\/\/doi.org\/10.1186\/s12888-023-05081-4.","journal-title":"BMC Psychiatry"},{"issue":"W1","key":"3709_CR14","doi-asserted-by":"publisher","first-page":"W398","DOI":"10.1093\/nar\/gkae253","volume":"52","author":"Z Pang","year":"2024","unstructured":"Pang Z, Lu Y, Zhou G, et al. MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation. Nucleic Acids Res. 2024;52(W1):W398\u2013406. https:\/\/doi.org\/10.1093\/nar\/gkae253.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"3709_CR15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11306-024-02140-z","volume":"20","author":"G Mu","year":"2024","unstructured":"Mu G, Cao X, Shao L, et al. Progress and perspectives of metabolic biomarkers in human aortic dissection. Metabolomics. 2024;20(4):76. https:\/\/doi.org\/10.1007\/s11306-024-02140-z.","journal-title":"Metabolomics"},{"issue":"1","key":"3709_CR16","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/s12916-022-02657-x","volume":"20","author":"P Li","year":"2022","unstructured":"Li P, Wang H, Guo L, et al. Association between gut microbiota and preeclampsia-eclampsia: a two-sample Mendelian randomization study. BMC Med. 2022;20(1):443. https:\/\/doi.org\/10.1186\/s12916-022-02657-x.","journal-title":"BMC Med"},{"issue":"2","key":"3709_CR17","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/jcsm.13174","volume":"14","author":"S Park","year":"2023","unstructured":"Park S, Kim SG, Lee S, et al. Causal linkage of tobacco smoking with ageing: Mendelian randomization analysis towards telomere attrition and sarcopenia. J Cachexia Sarcopenia Muscle. 2023;14(2):955\u201363. https:\/\/doi.org\/10.1002\/jcsm.13174.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"10","key":"3709_CR18","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1002\/ijc.34214","volume":"151","author":"Q Wang","year":"2022","unstructured":"Wang Q, Shi Q, Lu J, et al. Causal relationships between inflammatory factors and multiple myeloma: a bidirectional Mendelian randomization study. Int J Cancer. 2022;151(10):1750\u20139. https:\/\/doi.org\/10.1002\/ijc.34214.","journal-title":"Int J Cancer"},{"key":"3709_CR19","doi-asserted-by":"publisher","first-page":"940161","DOI":"10.3389\/fpubh.2022.940161","volume":"10","author":"RC Gao","year":"2022","unstructured":"Gao RC, Sang N, Jia CZ, et al. Association between sleep traits and rheumatoid arthritis: A Mendelian randomization study. Front Public Health. 2022;10:940161. https:\/\/doi.org\/10.3389\/fpubh.2022.940161.","journal-title":"Front Public Health"},{"key":"3709_CR20","doi-asserted-by":"publisher","first-page":"1157451","DOI":"10.3389\/fmicb.2023.1157451","volume":"14","author":"M Su","year":"2023","unstructured":"Su M, Tang Y, Kong W, et al. Genetically supported causality between gut microbiota, gut metabolites and low back pain: a two-sample Mendelian randomization study. Front Microbiol. 2023;14:1157451. https:\/\/doi.org\/10.3389\/fmicb.2023.1157451.","journal-title":"Front Microbiol"},{"issue":"6","key":"3709_CR21","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/qjmed\/hcad048","volume":"116","author":"Z Liang","year":"2023","unstructured":"Liang Z, Zhao L, Lou Y, et al. Causal effects of circulating lipids and lipid-lowering drugs on the risk of epilepsy: a two-sample Mendelian randomization study. QJM. 2023;116(6):421\u20138. https:\/\/doi.org\/10.1093\/qjmed\/hcad048.","journal-title":"QJM"},{"issue":"2","key":"3709_CR22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s11255-020-02624-6","volume":"53","author":"M Mazidi","year":"2021","unstructured":"Mazidi M, Shekoohi N, Katsiki N, et al. Longer sleep duration May negatively affect renal function. Int Urol Nephrol. 2021;53(2):325\u201332. https:\/\/doi.org\/10.1007\/s11255-020-02624-6.","journal-title":"Int Urol Nephrol"},{"issue":"11","key":"3709_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/genes13111967","volume":"13","author":"C Qin","year":"2022","unstructured":"Qin C, Chen Z, Cao R, et al. Integrated analysis of the fecal metagenome and metabolome in bladder cancer in a Chinese population. Genes. 2022;13(11):1967. https:\/\/doi.org\/10.3390\/genes13111967.","journal-title":"Genes"},{"issue":"8","key":"3709_CR24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.urolonc.2025.02.016","volume":"43","author":"G Lucarelli","year":"2025","unstructured":"Lucarelli G, Lasorsa F, Milella M, et al. Transcriptomic and proteo-metabolic determinants of the grading system in clear cell renal cell carcinoma. Urol Oncol. 2025;43(8):469. .e19-469.e32.","journal-title":"Urol Oncol"},{"issue":"12","key":"3709_CR25","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.3390\/cells9122600","volume":"9","author":"MP De Oliveira","year":"2020","unstructured":"De Oliveira MP, Liesa M. The role of mitochondrial fat oxidation in cancer cell proliferation and survival. Cells. 2020;9(12):2600. https:\/\/doi.org\/10.3390\/cells9122600.","journal-title":"Cells"},{"key":"3709_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.canlet.2018.08.006","volume":"435","author":"Y Ma","year":"2018","unstructured":"Ma Y, Temkin SM, Hawkridge AM, et al. Fatty acid oxidation: an emerging facet of metabolic transformation in cancer. Cancer Lett. 2018;435:92\u2013100. https:\/\/doi.org\/10.1016\/j.canlet.2018.08.006.","journal-title":"Cancer Lett"},{"issue":"6","key":"3709_CR27","doi-asserted-by":"publisher","first-page":"C1278","DOI":"10.1152\/ajpcell.00319.2019","volume":"317","author":"PC Turnbull","year":"2019","unstructured":"Turnbull PC, Hughes MC, Perry CGR. The fatty acid derivative palmitoylcarnitine abrogates colorectal cancer cell survival by depleting glutathione. Am J Physiol Cell Physiol. 2019;317(6):C1278\u201388. https:\/\/doi.org\/10.1152\/ajpcell.00319.2019.","journal-title":"Am J Physiol Cell Physiol"},{"key":"3709_CR28","doi-asserted-by":"publisher","first-page":"100878","DOI":"10.1016\/j.bbrep.2020.100878","volume":"25","author":"M Bagherzadeh-Yazdi","year":"2020","unstructured":"Bagherzadeh-Yazdi M, Bohlooli M, Khajeh M, et al. Acetoacetate enhancement of glucose mediated DNA glycation. Biochem Biophys Rep. 2020;25:100878. https:\/\/doi.org\/10.1016\/j.bbrep.2020.100878.","journal-title":"Biochem Biophys Rep"},{"issue":"12","key":"3709_CR29","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1080\/07391102.2015.1125790","volume":"34","author":"M Bohlooli","year":"2016","unstructured":"Bohlooli M, Ghaffari-Moghaddam M, Khajeh M, et al. Acetoacetate promotes the formation of fluorescent advanced glycation end products (AGEs). J Biomol Struct Dyn. 2016;34(12):2658\u201366. https:\/\/doi.org\/10.1080\/07391102.2015.1125790.","journal-title":"J Biomol Struct Dyn"},{"key":"3709_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.omtn.2020.01.037","volume":"20","author":"G Jin","year":"2020","unstructured":"Jin G, Xu M, Zou M, et al. The processing, gene regulation, biological functions, and clinical relevance of N4-acetylcytidine on RNA: a systematic review. Mol Ther. 2020;20:13\u201324. https:\/\/doi.org\/10.1016\/j.omtn.2020.01.037.","journal-title":"Mol Ther"},{"issue":"5","key":"3709_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.738","volume":"12","author":"G Wang","year":"2022","unstructured":"Wang G, Zhang M, Zhang Y, et al. NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression. Clin Transl Med. 2022;12(5):e738. https:\/\/doi.org\/10.1002\/ctm2.738.","journal-title":"Clin Transl Med"},{"issue":"1","key":"3709_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4103\/jcrt.JCRT_862_16","volume":"17","author":"MD Jelic","year":"2021","unstructured":"Jelic MD, Mandic AD, Maricic SM, et al. Oxidative stress and its role in cancer. J Cancer Res Ther. 2021;17(1):22\u20138. https:\/\/doi.org\/10.4103\/jcrt.JCRT_862_16.","journal-title":"J Cancer Res Ther"},{"key":"3709_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ymben.2020.03.010","volume":"60","author":"NP Lesner","year":"2020","unstructured":"Lesner NP, Gokhale AS, Kota K, et al. \u03b1-ketobutyrate links alterations in cystine metabolism to glucose oxidation in MtDNA mutant cells. Metab Eng. 2020;60:157\u201367. https:\/\/doi.org\/10.1016\/j.ymben.2020.03.010.","journal-title":"Metab Eng"},{"key":"3709_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2020.113134","volume":"183","author":"A Gupta","year":"2020","unstructured":"Gupta A, Bansal N, Mitash N, et al. NMR-derived targeted serum metabolic biomarkers appraisal of bladder cancer: a pre- and post-operative evaluation. J Pharm Biomed Anal. 2020;183:113134. https:\/\/doi.org\/10.1016\/j.jpba.2020.113134.","journal-title":"J Pharm Biomed Anal"},{"issue":"Pt 2","key":"3709_CR35","doi-asserted-by":"publisher","first-page":"143739","DOI":"10.1016\/j.ijbiomac.2025.143739","volume":"311","author":"R Chen","year":"2025","unstructured":"Chen R, Li Y, Zuo L, et al. Astragalus polysaccharides inhibits tumor proliferation and enhances cisplatin sensitivity in bladder cancer by regulating the PI3K\/AKT\/FoxO1 axis. Int J Biol Macromol. 2025;311(Pt 2):143739. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.143739.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"3709_CR36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.7150\/jca.50490","volume":"12","author":"F Li","year":"2021","unstructured":"Li F, Xie W, Fang Y, et al. HnRNP-F promotes the proliferation of bladder cancer cells mediated by PI3K\/AKT\/FOXO1. J Cancer. 2021;12(1):281\u201391. https:\/\/doi.org\/10.7150\/jca.50490.","journal-title":"J Cancer"},{"issue":"6","key":"3709_CR37","doi-asserted-by":"publisher","first-page":"4702","DOI":"10.3390\/curroncol28060396","volume":"28","author":"M Samara","year":"2021","unstructured":"Samara M, Papathanassiou M, Farmakioti I, et al. Renin-angiotensin system single nucleotide polymorphisms are associated with bladder cancer risk. Curr Oncol. 2021;28(6):4702\u20138. https:\/\/doi.org\/10.3390\/curroncol28060396.","journal-title":"Curr Oncol"},{"issue":"5","key":"3709_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2024.102143","volume":"22","author":"WP Skelton","year":"2024","unstructured":"Skelton WP, Masur J, Thomas J, et al. Impact of angiotensin converting enzyme inhibitors on pathologic complete response with neoadjuvant chemotherapy for muscle invasive bladder cancer. Clin Genitourin Cancer. 2024;22(5):102143. https:\/\/doi.org\/10.1016\/j.clgc.2024.102143.","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"3709_CR39","doi-asserted-by":"publisher","first-page":"e303","DOI":"10.1016\/j.clgc.2022.02.007","volume":"20","author":"G Motterle","year":"2022","unstructured":"Motterle G, Morlacco A, Giovannini G, et al. Role of Renin-Angiotensin system blockers on BCG response in nonmuscle Invasive, high risk bladder cancer. Clin Genitourin Cancer. 2022;20(4):e303\u20139. https:\/\/doi.org\/10.1016\/j.clgc.2022.02.007.","journal-title":"Clin Genitourin Cancer"},{"key":"3709_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122244","volume":"335","author":"SI Nayan","year":"2023","unstructured":"Nayan SI, Rahman MH, Hasan MM, et al. Network based approach to identify interactions between type 2 diabetes and cancer comorbidities. Life Sci. 2023;335:122244. https:\/\/doi.org\/10.1016\/j.lfs.2023.122244.","journal-title":"Life Sci"},{"issue":"4","key":"3709_CR41","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/17453674.2019.1612624","volume":"90","author":"J Ranstam","year":"2019","unstructured":"Ranstam J. Hypothesis-generating and confirmatory studies, Bonferroni correction, and pre-specification of trial endpoints. Acta Orthop. 2019;90(4):297. https:\/\/doi.org\/10.1080\/17453674.2019.1612624.","journal-title":"Acta Orthop"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03709-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03709-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03709-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T12:51:14Z","timestamp":1760446274000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03709-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3709"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03709-3","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"4 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study design did not involve direct engagement with human participants or the collection of primary data.\u00a0This study uses publicly available data and does not involve human participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have given their consent to publish the results of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1859"}}